6-143471469-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003630.3(PEX3):c.523+20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00315 in 1,571,440 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 68 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 63 hom. )
Consequence
PEX3
NM_003630.3 intron
NM_003630.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0290
Publications
0 publications found
Genes affected
PEX3 (HGNC:8858): (peroxisomal biogenesis factor 3) The product of this gene is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
PEX3 Gene-Disease associations (from GenCC):
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 10A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- peroxisome biogenesis disorder 10BInheritance: AR Classification: STRONG Submitted by: G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-143471469-C-T is Benign according to our data. Variant chr6-143471469-C-T is described in ClinVar as Benign. ClinVar VariationId is 259106.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0562 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PEX3 | NM_003630.3 | c.523+20C>T | intron_variant | Intron 6 of 11 | ENST00000367591.5 | NP_003621.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0165 AC: 2514AN: 152062Hom.: 67 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2514
AN:
152062
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00423 AC: 1058AN: 250250 AF XY: 0.00305 show subpopulations
GnomAD2 exomes
AF:
AC:
1058
AN:
250250
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00171 AC: 2425AN: 1419260Hom.: 63 Cov.: 25 AF XY: 0.00146 AC XY: 1031AN XY: 708520 show subpopulations
GnomAD4 exome
AF:
AC:
2425
AN:
1419260
Hom.:
Cov.:
25
AF XY:
AC XY:
1031
AN XY:
708520
show subpopulations
African (AFR)
AF:
AC:
1971
AN:
32650
American (AMR)
AF:
AC:
116
AN:
44618
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25818
East Asian (EAS)
AF:
AC:
0
AN:
39388
South Asian (SAS)
AF:
AC:
11
AN:
84764
European-Finnish (FIN)
AF:
AC:
0
AN:
53290
Middle Eastern (MID)
AF:
AC:
9
AN:
5696
European-Non Finnish (NFE)
AF:
AC:
106
AN:
1074154
Other (OTH)
AF:
AC:
212
AN:
58882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
114
229
343
458
572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0165 AC: 2518AN: 152180Hom.: 68 Cov.: 32 AF XY: 0.0157 AC XY: 1171AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
2518
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
1171
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
2414
AN:
41508
American (AMR)
AF:
AC:
63
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18
AN:
67982
Other (OTH)
AF:
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
127
253
380
506
633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3468
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Apr 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.